---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-031123"
form_type: "8-K"
ticker: "MBRX"
cik: "0001659617"
company_name: "Moleculin Biotech, Inc."
filed_at: "2025-10-16T23:59:59+00:00"
generated_at: "2026-05-17T03:34:14.162857+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Moleculin Biotech special meeting: name change proposal fails; warrant issuance approved

## Summary
- Stockholders rejected name change to Moleculin Inc.; needed majority of 36.7M outstanding shares but only 11.3M voted For.
- Approved issuance of up to 64.9M shares upon exercise of warrants issued Aug 28, 2025 (4.9M For, 1.5M Against).
- Adjournment proposal passed (5.6M For) to allow further proxy solicitation if needed.
- Broker non-votes totaled 8.2M for warrants and adjournment proposals.

## SEC filing metadata
- accession: 0001437749-25-031123
- form_type: 8-K
- ticker: MBRX
- cik: 0001659617
- company_name: Moleculin Biotech, Inc.
- filed_at: 2025-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659617/000143774925031123/0001437749-25-031123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659617/000143774925031123/mbrx20251013_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-031123
- JSON: https://secwatch.observer/filing/0001437749-25-031123.json
- Plain text: https://secwatch.observer/filing/0001437749-25-031123.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.